BLB&B Advisors’s Neuronetics STIM Stock Holding History

BLB&B Advisors’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-14,000	Closed	-$10.6K	–	287
2024 Q3	$10.6K	Buy	+14,000	New	+$18.4K	﹤0.01%	282
2023 Q4	–	Sell	-29,937	Closed	-$40.4K	–	260
2023 Q3	$40.4K	Hold	29,937	–	–	﹤0.01%	240
2023 Q2	$64.4K	Buy	+29,937	New	+$72.6K	﹤0.01%	241

Other funds holding STIM

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

BLB&B Advisors's STIM Position: Q4 2024 in Review

BLB&B Advisors sold out of Neuronetics (STIM) in Q4 2024, closing a stake of 14,000 shares — an estimated $10.6K sold.

BLB&B Advisors first reported a position in STIM in Q2 2023 and held it in 3 quarters. The position peaked at $64.4K in Q2 2023. 45 funds tracked by Wall St. Rank hold STIM as of Q4 2024.

BLB&B Advisors reported no remaining Neuronetics position as of Q4 2024 after selling out during the quarter.
BLB&B Advisors sold 14,000 Neuronetics shares in Q4 2024, an estimated $10.6K.
BLB&B Advisors first reported a position in Neuronetics in Q2 2023 and held it in 3 quarters.
BLB&B Advisors's Neuronetics position peaked at $64.4K in Q2 2023.
45 funds tracked by Wall St. Rank held Neuronetics as of Q4 2024.

Based on BLB&B Advisors's 13F filing for Q4 2024, filed 28 Jan 2025.